Cargando…
Is metformin a miracle or a menace in COVID‐19 patients with type 2 diabetes?
[Image: see text]
Autores principales: | Lui, David Tak Wai, Tan, Kathryn Choon Beng |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8015825/ https://www.ncbi.nlm.nih.gov/pubmed/33331120 http://dx.doi.org/10.1111/jdi.13484 |
Ejemplares similares
-
One year into the clash of pandemics of diabetes and COVID‐19: Lessons learnt and future perspectives
por: Lui, David Tak Wai, et al.
Publicado: (2021) -
Effect of type 2 diabetes on the inducible degrader of LDL receptor
por: Lam, Sum, et al.
Publicado: (2023) -
Commentary: Pythium keratitis: The masquerading menace!
por: Kulkarni, Uma
Publicado: (2023) -
Curbing the menace of antimicrobial resistance in developing countries
por: Nweneka, Chidi Victor, et al.
Publicado: (2009) -
Cardiovascular benefits of SGLT2 inhibitors in type 2 diabetes, interaction with metformin and role of erythrocytosis: a self-controlled case series study
por: Wong, Carlos King Ho, et al.
Publicado: (2022)